Now showing items 1-3 of 3

    • Immunogenic cell death in cancer therapy 

      Meier P; Goode, E; Meier, P (Institute of Cancer Research (University Of London), 2024-01-16)
      Triple negative breast cancer (TNBC) is a heterogenous disease which carries a poor prognosis, with the worst outcomes in the basal-like subtype. Despite the introduction of immunotherapy in the treatment paradigm the ...
    • The combination of vemurafenib and cobimetinib in advanced melanoma 

      Spain, L; Goode, E; McGovern, Y; Joshi, K; Larkin, J (TAYLOR & FRANCIS LTD, 2016-11-01)
    • The Diversification of Cell Death and Immunity: Memento Mori. 

      Legrand, AJ; Konstantinou, M; Goode, EF; Meier, P (CELL PRESS, 2019-10-01)
      Why do cells have so many ways to die? Why does "cellular suicide" exist at all? In the war against pathogens and rogue cells, organisms developed cellular suicide as a last resort. Fighting an evolutionary arms race, cell ...